Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 11-20 of 1774


Genetic Discrimination Means the Choice Between Life and Life Insuranceby Shimon Koffler Fogel and Bev Heim-MyersHuffington Post [Canada]December 12th, 2014Unfortunately, Canadians across the country currently face real as well as potential future discrimination based on their DNA.
Have New Prenatal Tests Been Dangerously Oversold?by Beth DaleyNew England Center for Investigative ReportingDecember 12th, 2014Many prenatal testing companies promise more than they can deliver. Two studies show that results can be a false alarm half of the time.
California Launches $50 Million, Fast-Track Stem Cell Driveby David JensenCalifornia Stem Cell ReportDecember 11th, 2014The California stem cell agency approved a plan that will radically reshape its efforts to produce a widely available stem cell treatment, a goal it has not yet reached after 10 years of trying.
CRISPR Opportunities ... For What? And for Whom?by Pete ShanksHuffington PostDecember 10th, 2014Money and deals are flowing into companies that promise to edit genes. Human, animal, plant, all kinds of DNA may be on the cutting board.
Stem Cells: The Black Box of Reprogrammingby David CyranoskiNature NewsDecember 10th, 2014Scientists have been reprogramming adult cells into embryonic ones for decades — but they are only now getting to grips with the mechanics.
The NFL Has a Problem with Stem Cell Treatmentsby Antonio RegaladoMIT Technology ReviewDecember 10th, 2014Professional athletes are getting injections of stem cells to speed up recovery from injury. Critics call it a high-tech placebo.
Commercialisation and the Moral Obligation to Create 'Designer' Babiesby John GallowayBioNewsDecember 8th, 2014Julian Savulescu made the case for a new 'eugenics', without ever using the word, at Progress Educational Trust's 2014 annual conference.
Did NBC News Err On Key Part of Their Stem Cell Report?by Paul KnoepflerKnoepfler Lab Stem Cell BlogDecember 7th, 2014Overall this was a well-done report, but NBC made the bombshell claim that the FDA does not regulate unapproved stem cell “treatments.” This seems very difficult to believe.
Couple Spends $50K to Choose Baby's Sex, Shining Light on Trend[Quotes CGS's Marcy Darnovsky]by Beth GreenfieldYahooDecember 5th, 2014What if a boy wants to write poetry? What if a girl wants to play basketball? Not wear dresses? Announce that she’s transgender?
Who Owns the Biggest Biotech Discovery of the Century?by Antonio RegaladoMIT Technology ReviewDecember 4th, 2014At stake are rights to an invention that may be the most important new genetic engineering technique since the beginning of the biotechnology age in the 1970s: the CRISPR system.
Displaying 11-20 of 1774  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760